Back to Maryland

SB0562 • 2026

State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders

State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders

Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor
Senator Gile
Last action
2026-04-14
Official status
Approved by the Governor - Chapter 54
Effective date
2026-07-01

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders

Authorizing licensed certified midwives to enter into therapy management contracts; repealing a requirement that authorized prescribers submit prescriber-pharmacist agreements to the health occupations board that regulates the authorized prescriber; authorizing pharmacists, under certain circumstances, to enter into prescriber-pharmacist agreements that authorize the pharmacist to treat an opioid use disorder using controlled dangerous substances drug therapy; etc.

What This Bill Does

  • Authorizing licensed certified midwives to enter into therapy management contracts; repealing a requirement that authorized prescribers submit prescriber-pharmacist agreements to the health occupations board that regulates the authorized prescriber; authorizing pharmacists, under certain circumstances, to enter into prescriber-pharmacist agreements that authorize the pharmacist to treat an opioid use disorder using controlled dangerous substances drug therapy; etc.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

883029/1

None

Favorable with Amendments { 883029/1 Adopted

Plain English: AMENDMENTS TO SENATE BILL 562 (First Reading File Bill) AMENDMENT NO.

  • AMENDMENTS TO SENATE BILL 562 (First Reading File Bill) AMENDMENT NO.
  • 1 On page 1, in line 4, after “of” insert “ authorizing licensed certified midwives to enter into therapy management contracts;”; after line 12, insert: “BY repealing and reenacting, without amendments, Article - Health Occupations Section 12-6A-01(a) Annotated Code of Maryland (2021 Replacement Volume and 2025 Supplement)”; and in line 15, after “Section” insert “12–6A–01(b),”.
  • AMENDMENT NO.
  • 2 On page 1, after line 20, insert: “12–6A–01.

Bill History

  1. 2026-04-14 Post Passage

    Approved by the Governor - Chapter 54

  2. 2026-04-01 House

    Favorable Report by Health

  3. 2026-03-17 House

    Hearing 3/25 at 1:00 p.m.

  4. 2026-03-17 House

    Third Reading Passed (132-0)

  5. 2026-03-16 House

    Favorable Adopted Second Reading Passed

  6. 2026-03-16 Senate

    Returned Passed

  7. 2026-03-09 Senate

    Favorable with Amendments Report by Finance

  8. 2026-03-01 House

    Referred Health

  9. 2026-02-27 Senate

    Third Reading Passed (45-0)

  10. 2026-02-25 Senate

    Favorable with Amendments { 883029/1 Adopted

  11. 2026-02-25 Senate

    Second Reading Passed with Amendments

  12. 2026-02-12 Senate

    Hearing 3/03 at 1:00 p.m.

  13. 2026-02-04 Senate

    First Reading Finance

  14. Maryland General Assembly

    Text - First - State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders

  15. Maryland General Assembly

    Vote - Senate - Committee - Finance

  16. Maryland General Assembly

    Text - Third - State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders

  17. Maryland General Assembly

    Vote - House - Committee - Health

  18. Maryland General Assembly

    Text - Chapter - State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders

Official Summary Text

Authorizing licensed certified midwives to enter into therapy management contracts; repealing a requirement that authorized prescribers submit prescriber-pharmacist agreements to the health occupations board that regulates the authorized prescriber; authorizing pharmacists, under certain circumstances, to enter into prescriber-pharmacist agreements that authorize the pharmacist to treat an opioid use disorder using controlled dangerous substances drug therapy; etc.

Current Bill Text

Read the full stored bill text
EXPLANATION: CAPITALS INDICATE MATTER ADDED TO EXISTING LAW.
[Brackets] indicate matter deleted from existing law.
Underlining indicates amendments to bill.
Strike out indicates matter stricken from the bill by amendment or deleted from the law by
amendment.
*sb0562*

SENATE BILL 562
J2, J1 6lr1784
CF HB 838
By: Senator Gile
Introduced and read first time: February 4, 2026
Assigned to: Finance
Committee Report: Favorable with amendments
Senate action: Adopted
Read second time: February 25, 2026

CHAPTER ______

AN ACT concerning 1

State Board of Pharmacy – Prescriber–Pharmacist Agreements – Treatment of 2
Opioid Use Disorders 3

FOR the purpose of authorizing licensed certified midwives to enter into therapy 4
management contracts; repealing a requirement that authorized prescribers submit 5
prescriber–pharmacist agreements to the health occupations board that regulates 6
the authorized prescriber; authorizing pharmacists, under certain circumstances, to 7
enter into prescriber–pharmacist agreements that authorize the pharmacist to treat 8
an opioid use disorder using controlled dangerous substances drug therapy; 9
requiring that a protocol that authorizes controlled dange rous substances drug 10
therapy require a pharmacist to request certain data from the Prescription Drug 11
Monitoring Program before initiating or modifying a controlled dangerous 12
substances therapy; and generally relating to prescriber–pharmacist agreements. 13

BY repealing and reenacting, without amendments, 14
Article – Health Occupations 15
Section 12–6A–01(a) 16
Annotated Code of Maryland 17
(2021 Replacement Volume and 2025 Supplement) 18

BY repealing and reenacting, with amendments, 19
Article – Health Occupations 20
Section 12–6A–01(b), 12–6A–03, 12–6A–04, and 12–6A–06 21
Annotated Code of Maryland 22
(2021 Replacement Volume and 2025 Supplement) 23
2 SENATE BILL 562

SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 1
That the Laws of Maryland read as follows: 2

Article – Health Occupations 3

12–6A–01. 4

(a) In this subtitle the following words have the meanings indicated. 5

(b) “Authorized prescriber” means a licensed physician, licensed podiatrist, 6
CERTIFIED MIDWIFE LICENSED UNDER TITLE 8, SUBTITLE 6D OF THIS ARTICLE, or 7
certified advanced practice nurse with prescriptive authority under § 8–508 of this article. 8

12–6A–03. 9

(a) An authorized prescriber and a licensed pharmacist who wish to enter into 10
therapy management contracts shall have a prescriber–pharmacist agreement. 11

(b) [(1) (i) Except as provided in subparagraph (ii) of this paragraph, an 12
authorized prescriber who has entered into a prescriber –pharmacist agreement shall 13
submit to the health occupations board that regulates the authorized prescriber a copy of 14
the prescri ber–pharmacist agreement and any subsequent modifications made to the 15
prescriber–pharmacist agreement or the protocols specified in the prescriber –pharmacist 16
agreement. 17

(ii) A health occupations board may enter into an agreement with 18
the Board of Pharm acy that requires authorized prescribers regulated by the health 19
occupations board to submit to the Board of Pharmacy documentation that otherwise would 20
be required to be submitted to the health occupations board under subparagraph (i) of this 21
paragraph. 22

(2)] A licensed pharmacist who has entered into a prescriber –pharmacist 23
agreement shall submit to the Board of Pharmacy a copy of the prescriber –pharmacist 24
agreement and any subsequent modifications made to the prescriber –pharmacist 25
agreement or the protocols specified in the prescriber–pharmacist agreement. 26

12–6A–04. 27

(A) [A] SUBJECT TO SUBSECTION (B) OF THIS SECTION , A pharmacist is 28
authorized to enter into a prescriber–pharmacist agreement if the pharmacist: 29

(1) Is a licensed pharmacist; 30

(2) Has a Doctor of Pharmacy Degree or equivalent training as established 31
in regulations adopted under this subtitle; 32

SENATE BILL 562 3

(3) Is approved by the Board to enter into a prescriber –pharmacist 1
agreement with an authorized prescriber in accordance with this subtitle; and 2

(4) Meets the requirements that are established by regulations adopted 3
under this subtitle. 4

(B) A PHARMACIST MAY ENTER INTO A PRESCRIBER –PHARMACIST 5
AGREEMENT THAT AUTHORIZES A PHARMACIST TO TREAT AN OPIOID USE DISORDER 6
USING CONTROLLED DAN GEROUS SUBSTANCES DRUG THER APY IF THE 7
PHARMACIST: 8

(1) INDIVIDUALLY REGISTER S WITH THE FEDERAL DRUG 9
ENFORCEMENT AGENCY; 10

(2) INDIVIDUALLY REGISTERS WITH THE OFFICE OF CONTROLLED 11
SUBSTANCES ADMINISTRATION; 12

(3) COMPLETES ANY APPLICABLE TRAINING REQUIRED BY FEDERAL 13
OR STATE LAWS; AND 14

(4) FOLLOWS A PROTOCOL TH AT MEETS THE REQUIRE MENTS OF § 15
12–6A–06 OF THIS SUBTITLE. 16

12–6A–06. 17

(a) A protocol under this subtitle: 18

(1) May authorize: 19

(i) For protocols by a licensed physician and licensed pharmacist, 20
the initiation of drug therapy under written, disease–state specific protocols; 21

(ii) The modification, continuation, and discontinuation of drug 22
therapy under written, disease–state specific protocols; 23

(iii) The ordering of laboratory tests; and 24

(iv) Other patient care management measures related to monitoring 25
or improving the outcomes of drug or device therapy; and 26

(2) May not authorize acts that exceed the scope of practice of the parties 27
to the therapy management contract. 28

(b) A protocol shall prohibit the substitution of a chemically dissimilar drug 29
product by the pharmacist for the product prescribed by the authorized prescriber, unless 30
permitted in the therapy management contract. 31
4 SENATE BILL 562

(C) A PROTOCOL THAT AUTHOR IZES CONTROLLED DANG EROUS 1
SUBSTANCES DRUG THERA PY SHALL REQUIRE THE PHARMACIST TO REQUES T 2
RELEVANT DATA FROM THE PRESCRIPTION DRUG MONITORING PROGRAM BEFORE 3
INITIATING OR MODIFY ING A CONTROLLED DAN GEROUS SUBSTANCES DR UG 4
THERAPY. 5

SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect July 6
1, 2026. 7

Approved:
________________________________________________________________________________
Governor.
________________________________________________________________________________
President of the Senate.
________________________________________________________________________________
Speaker of the House of Delegates.